GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PELL Bio-Med Technology Co Ltd (TPE:6949) » Definitions » Issuance of Stock

PELL Bio-Med Technology Co (TPE:6949) Issuance of Stock : NT$918.63 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is PELL Bio-Med Technology Co Issuance of Stock?

PELL Bio-Med Technology Co's Issuance of Stock for the three months ended in Sep. 2024 was NT$1.80 Mil.

PELL Bio-Med Technology Co's Issuance of Stock for the trailing twelve months (TTM) ended in Sep. 2024 was NT$918.63 Mil.


PELL Bio-Med Technology Co Issuance of Stock Historical Data

The historical data trend for PELL Bio-Med Technology Co's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PELL Bio-Med Technology Co Issuance of Stock Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23
Issuance of Stock
5.02 759.34 625.77

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.76 592.98 311.15 12.70 1.80

PELL Bio-Med Technology Co Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$918.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PELL Bio-Med Technology Co Issuance of Stock Related Terms

Thank you for viewing the detailed overview of PELL Bio-Med Technology Co's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


PELL Bio-Med Technology Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell).

PELL Bio-Med Technology Co Headlines

No Headlines